Literature DB >> 28263933

Microvascular Decompression for Glossopharyngeal Neuralgia: Long-Term Follow-Up.

Hua Zhao1, Xin Zhang1, Jin Zhu1, Yin-da Tang1, Shi-Ting Li2.   

Abstract

OBJECTIVE: To examine operative findings and outcome of microvascular decompression (MVD) for glossopharyngeal neuralgia (GPN). This research displayed the long-term outcomes of a large series of 35 cases with GPN treated with MVD.
METHODS: From January 2004 to June 2006, 35 consecutive patients were diagnosed with GPN. All of them underwent MVD. Demographic data, clinical presentation, operative findings, clinical results, operative complications were reviewed.
RESULTS: A total of 33 patients (94.3%) experienced complete pain relief immediately after MVD. Long-term follow-up was available for 30 of these 35 patients, and 28 of these 30 patients continued to be pain-free. There was no long-term operative morbidity in all cases. One patient had a cerebrospinal fluid leak and 1 case presented with delayed facial palsy.
CONCLUSIONS: Classic GPN is usually caused by pulsatile neurovascular compression of the glossopharyngeal and vagus rootlets. MVD is a safe, effective, and durable operation for GPN.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glossopharyngeal neuralgia; Microvascular decompression; Vagoglossopharygeal neuralgia

Mesh:

Year:  2017        PMID: 28263933     DOI: 10.1016/j.wneu.2017.02.106

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Microvascular Decompression for Glossopharyngeal Neuralgia: Clinical Analyses of 30 Cases.

Authors:  Mi Kyung Kim; Jae Sung Park; Young Hwan Ahn
Journal:  J Korean Neurosurg Soc       Date:  2017-10-25

2.  Gradual aggravation of idiopathic glossopharyngeal neuralgia due to chronic tonsillitis: A case report.

Authors:  EunSoo Kim; Wangseok Do; Young-Hoon Jung; Jiyoun Lee; Jiseok Baik
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.